Literature DB >> 9484990

Prolonged activation of prothrombin on the vascular wall after arterial injury.

G Ghigliotti1, A R Waissbluth, C Speidel, D R Abendschein, P R Eisenberg.   

Abstract

This study was designed to characterize the relative roles of bound Xa/Va and thrombin activity in vascular wall procoagulant activity after balloon-induced injury and the extent to which intravenous aspirin and heparin attenuate procoagulant activity associated with the vascular wall. Abdominal aortic injury was induced in rabbits by overinflation and multiple passages ofa 4F embolectomy catheter. Rabbits were killed 15 minutes or 4, 8, 24, 48, 72, 96, or 120 hours after injury. Aortic segments were incubated ex vivo to define bound procoagulant activity. Thrombin activity bound to the aorta was detected by 4 hours after injury and was most marked over the first 24 hours, as estimated by increases in concentration of fibrinopeptide A during incubation of segments with recalcified barium-adsorbed plasma or activity against the thrombin-synthetic substrate S-2238. Based on comparison with purified human thrombin incubated under the same conditions, a maximum of 0.04 to 0.1 nmol/L per square centimeter of thrombin activity was associated with the vascular wall during the first 24 hours and remained detectable for 72 hours. In contrast, bound Xa/Va complex activity to injured segments was detected within 15 minutes and induced activation of prothrombin added to recalcified barium-adsorbed plasma incubated with injured segments for 96 hours. Aspirin (15 mg/kg) administered 30 minutes before injury attenuated 111In-platelet deposition at 4 hours by 67%, with an associated decrease in bound Xa/Va and thrombin activity at 15 minutes and 4 hours. However, intravenous heparin did not attenuate bound Xa/Va activity at 15 minutes or thrombin activity at 15 minutes and 4 hours. Platelet-dependent bound Xa/Va activity occurs rapidly after arterial injury and may promote thrombin elaboration for up to 96 hours. Bound thrombin activity and de novo thrombin elaboration on the vascular wall may play an important role in the progression of thrombosis and vascular wall remodeling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484990     DOI: 10.1161/01.atv.18.2.250

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

1.  Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.

Authors:  J Myerson; L He; G Lanza; D Tollefsen; S Wickline
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

2.  Impact of the learning curve for endoscopic vein harvest on conduit quality and early graft patency.

Authors:  Pranjal Desai; Soroosh Kiani; Nannan Thiruvanthan; Stanislav Henkin; Dinesh Kurian; Pluen Ziu; Alex Brown; Nisarg Patel; Robert Poston
Journal:  Ann Thorac Surg       Date:  2011-05       Impact factor: 4.330

3.  Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.

Authors:  Yung-Hsin Yeh; Shang-Hung Chang; Shin-Yu Chen; Chih-Jen Wen; Fu-Chan Wei; Rui Tang; Sam Achilefu; Tze-Chein Wun; Wei-Jan Chen
Journal:  Int J Cardiol       Date:  2017-04-06       Impact factor: 4.164

4.  Targeting atherosclerosis by using modular, multifunctional micelles.

Authors:  David Peters; Mark Kastantin; Venkata Ramana Kotamraju; Priya P Karmali; Kunal Gujraty; Matthew Tirrell; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

5.  Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension.

Authors:  Aiko Ogawa; Amy L Firth; Sanae Ariyasu; Ichiro Yamadori; Hiromi Matsubara; Shanshan Song; Dustin R Fraidenburg; Jason X-J Yuan
Journal:  Physiol Rep       Date:  2013-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.